ABVC Biopharma regains compliance with Nasdaq Shareholder Approval Rules

ABVC BIOPHARMA, INC.

Received Nasdaq notification on Sept 6, 2024 confirming compliance with Listing Rules 5635(a)(1) and 5635(a)(2).
Compliance based on Board Resolution dated May 16, 2024.
Regained compliance for continued listing on Nasdaq Capital Market.

item 8.01

ABVC BIOPHARMA, INC. filing history →

Source: SEC EDGAR

accession 0001213900-24-077361

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.